TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
PHAT

Phathom Pharmaceuticals Inc

Healthcare · Biotechnology

7.00$ -10.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PHAT
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +0.0% +3,937.5% +61.3% +19.0% -7.3% +38.3% -20.4%
– – +1,338.4% +187.9% +43.5% +86.6% -46.6% +19.4%
– +455,352.0% -97.3% +207.0% +131.0% – – –
– -4,528.8% – -152.8% – -350.9% – –
– +19,028.8% -95.9% -68.5% +217.4% +57.0% -91.7% +69.6%
– +0.0% -95.9% -68.5% +217.4% +57.0% -91.7% +69.6%
– +9,573,500.0% -99.7% +209.1% – – – –
– +5,856.5% -77.9% +71.1% +123.2% -58.8% +51.1% -100.0%
– +15,917.1% -62.4% -60.9% +168.5% +206.2% -50.3% -100.2%
– +27,532.1% -82.0% -338.0% – – -136.8% –
– – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?